谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Is Glucagon-Like Peptide-1 Fully Protected by the Dipeptidyl Peptidase 4 Inhibitor Sitagliptin when Administered to Patients with Type 2 Diabetes?

Emilie S. Andersen,Asger Lund,Jonatan I. Bagger,Camilla Andreasen,Magnus F. Grondahl,Carolyn F. Deacon,Bolette Hartmann,Jens J. Holst,Filip K. Knop,Tina Vilsboll

Diabetes, obesity & metabolism/Diabetes, obesity and metabolism（2018）

引用 4|浏览34
暂无评分
关键词
dipeptidyl peptidase 4,glucagon-like peptide-1,sitagliptin,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要